Admed Pharma Private Limited

Admed Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U36900DL2020PTC372472 Incorporated 30 October 2020 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹44.5 Cr
▲ 17% YoY
Net profit · FY 2025
₹27.95 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹2.65 Cr
EBITDA margin 6%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹17.7 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
88
Provident fund records

About Admed Pharma Private Limited

Data last updated:

Admed Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 October 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36900DL2020PTC372472. Its GSTIN is 02AAUCA3078M1Z9 (Himachal Pradesh).

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Surinder Kumar Sharma and Ashutosh Goel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 4 Upper Ground Floor Pushpanjli Enclave Pitampura, Delhi, India – 110034.

As per the financials filed for FY 2025, the company reported a revenue of ₹44.5 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹27.95 Lakh (net margin 0.6%) and EBITDA of ₹2.65 Cr (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years.

The company has about 88 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹17.7 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 2 cases are pending.

Admed Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0010463). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U36900DL2020PTC372472
Registration Number 372472
Incorporation Date 30 October 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0010463
Key People
Surinder Kumar Sharma Director Ashutosh Goel Director Mayank Goel Director

Recognitions & Rankings of Admed Pharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-HP-11-0010463

Contact details

Admed Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    A – 4 Upper Ground Floor Pushpanjli Enclave Pitampura, Delhi, India – 110034
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Admed Pharma Private Limited, buy the company report.

Comprehensive company report
Admed Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Admed Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Admed Pharma Private Limited, buy the company report.

Financials of Admed Pharma Private Limited

FY 2025 filings available

Admed Pharma Private Limited reported revenue of ₹44.5 Cr (up 17% YoY) for FY 2025.

Revenue · FY 2025
₹44.5 Cr ▲ 17%
Net profit · FY 2025
₹27.95 Lakh margin 0.6%
EBITDA · FY 2025
₹2.65 Cr margin 6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 68%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▲ 42%

Revenue has grown at a compounded annual rate (CAGR) of 68% over three years, including 17% growth in the latest year. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.65 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹27.95 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Admed Pharma Private Limited, buy the company report.

Board of directors of Admed Pharma Private Limited

Admed Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Surinder Kumar SharmaDirector15 Jul 20233 Years 3 MonthsCurrent
Ashutosh Goel
Also directs: Gangesh Renewable Energy LLP, Gangesh Reality LLP, Admed Overseas LLP and 4 more
Director30 Oct 20206 Years 0 MonthsCurrent
Mayank Goel
Also directs: Gangesh Renewable Energy LLP, Gangesh Reality LLP, Admed Overseas LLP and 5 more
Director30 Oct 20206 Years 0 MonthsCurrent
View all directors

Peer comparison

Admed Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Zenotech Laboratories Limited₹44.6 Cr (FY 2025)7.0%Hyderabad, Telangana, India
Deccan Remedies Ltd₹44.53 Cr (FY 2025)117.0%Hyderabad, Telangana, India
Admed Pharma Private Limitedthis company₹44.5 Cr (FY 2025)₹27.95 Lakh0.6%17.0%88Delhi, India
Lincoln Parenteral Limited₹44.48 Cr (FY 2020)-13.0%Ahmedabad, Gujarat, India
Avantika Medex Private Limited₹44.37 Cr (FY 2025)-14.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Admed Pharma Private Limited, buy the company report.

Auditor

Admed Pharma Private Limited is audited by PRANV & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
PRANV & ASSOCIATESFY 2024037916N

Shareholding

The shareholding of Admed Pharma Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Admed Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹17.7 Cr
Satisfied charges
None
Breakdown by lending institutions
Axis Bank Limited₹17.70 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Feb 2022100553299Axis Bank Limited₹9.7 CrOpen
25 Feb 2022100553290Axis Bank Limited₹8 CrOpen

To see the full charge records of Admed Pharma Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

Admed Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Sep 2023, listing 18 overdue payments to 18 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 18)

SupplierAmount dueDue sinceReported on
S K Jain Trading Private Limited
an individual supplier
an individual supplier
an individual supplier
Alben Chemicals Private Limited

To see the full MSME payment records of Admed Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Admed Pharma Private Limited has a workforce of 88 employees on its EPFO records as of Feb 18, 2025, across 2 active EPFO establishments.

Employee count
88
Active EPFO establishments
2
Employee growth
25.71%

GST

Admed Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
02AAUCA3078M1Z9Himachal PradeshActive08 Feb 2021

To see the full GST registrations and return filing status of Admed Pharma Private Limited, buy the company report.

Recent activity

Admed Pharma Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Surinder Kumar Sharma ceased to be Additional Director on 29 Sep 2023.

AGM
Admed Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Admed Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Axis Bank Limited of Rs. 970.00 Lakh registered on 28 Feb 2022 with Charge ID 100553299 was modified on 09 Dec 2024.
Charges
A charge with Axis Bank Limited of Rs. 800.00 Lakh registered on 25 Feb 2022 with Charge ID 100553290 was modified on 06 Dec 2024.
Ceased
Surinder Kumar Sharma ceased to be Additional Director.
Appointed
Surinder Kumar Sharma was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 970.00 Lakh with Charge ID 100553299 was registered on 28 Feb 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 800.00 Lakh with Charge ID 100553290 was registered on 25 Feb 2022.
Appointed
Ashutosh Goel was appointed as Director.
Appointed
Mayank Goel was appointed as Director.
Incorporation
30 Oct 2020
Admed Pharma Private Limited was registered on 30 Oct 2020 with Roc Delhi & aged 6 years 2 days as per MCA records.

Frequently asked questions

Admed Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 October 2020 (6+ years old) and is registered under CIN U36900DL2020PTC372472.

Admed Pharma has 3 current directors:

The latest financial statements of Admed Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Admed Pharma is 02AAUCA3078M1Z9, registered in Himachal Pradesh.

The CIN (Corporate Identification Number) of Admed Pharma is U36900DL2020PTC372472. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Admed Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. 2 are pending.

Admed Pharma was incorporated on 30 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Admed Pharma by revenue are Zenotech Laboratories Limited, Deccan Remedies Ltd, Lincoln Parenteral Limited, Avantika Medex Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Surinder Kumar Sharma ceased to be Additional Director on 29 Sep 2023. Surinder Kumar Sharma was appointed as Director on 15 Jul 2023. Ashutosh Goel was appointed as Director on 30 Oct 2020. Admed Pharma has 4 board changes on record in total.

Yes, Admed Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0010463).

Admed Pharma has 1 MSME Form 1 return on record for the period ending Sep 2023, listing 18 overdue payments to 18 micro and small suppliers. The latest return was filed on 08 Nov 2023.

The registered office of Admed Pharma is at A – 4 Upper Ground Floor Pushpanjli Enclave Pitampura, Delhi, India – 110034.